Adhera Therapeutics Inc (ATRX)
Adhera Therapeutics Inc operates in the Biotechnology industry of the Healthcare sector, headquartered in Baton Rouge, LA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $722. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of 0.0%. Its beta of 873.86 implies it has historically moved more than the broad market.
Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson’s disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
Adhera Therapeutics Inc is most often compared with the following Healthcare names: